Back to results

Liver Transplantation and Metastatic Colo-rectal Cancer.

Primary Purpose

Colo-rectal Cancer

Status

Active

Phase

Phase 2

Locations

Norway

Study Type

Interventional

Intervention

Liver transplantation and colo-rectal cancer

About this trial

This is an interventional treatment trial for Colo-rectal Cancer focused on measuring Liver transplantation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:Colo-rectal cancer - Exclusion Criteria: -

Sites / Locations

Rikshospitalet-Radiumhospitalet HF

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Liver transplantation

Arm Description

Outcomes

Primary Outcome Measures

Survival

Secondary Outcome Measures

Time to progression side-effects

Full Information

NCT ID

NCT00294827

First Posted

February 21, 2006

Last Updated

October 4, 2022

Sponsor

Oslo University Hospital

1. Study Identification

Unique Protocol Identification Number

NCT00294827

Brief Title

Liver Transplantation and Metastatic Colo-rectal Cancer.

Official Title

Liver Transplantation and Metastatic Colo-rectal Cancer.

Study Type

Interventional

2. Study Status

Record Verification Date

October 2022

Overall Recruitment Status

Active, not recruiting

Study Start Date

February 2006 (undefined)

Primary Completion Date

March 2023 (Anticipated)

Study Completion Date

March 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Principal Investigator

Name of the Sponsor

Oslo University Hospital

4. Oversight

5. Study Description

Brief Summary

Survival of colo-rectal cancer patients after liver transplantation.

Detailed Description

Survival, time to progression, other malignancy, side-effects, quality of life.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Colo-rectal Cancer

Keywords

Liver transplantation

7. Study Design

Primary Purpose

Treatment

Study Phase

Phase 2

Interventional Study Model

Single Group Assignment

Masking

None (Open Label)

Allocation

N/A

Enrollment

25 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title

Liver transplantation

Arm Type

Experimental

Intervention Type

Procedure

Intervention Name(s)

Liver transplantation and colo-rectal cancer

Intervention Description

Liver transplantation

Primary Outcome Measure Information:

Title

Survival

Time Frame

6 years

Secondary Outcome Measure Information:

Title

Time to progression side-effects

Time Frame

6 years

10. Eligibility

Sex

All

Minimum Age & Unit of Time

18 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria:Colo-rectal cancer - Exclusion Criteria: -

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Svein Dueland, MD, PhD

Organizational Affiliation

Rikshospitalet-Radiumhospitalet RRHF

Official's Role

Principal Investigator

Facility Information:

Facility Name

Rikshospitalet-Radiumhospitalet HF

City

Oslo

ZIP/Postal Code

0020

Country

Norway

12. IPD Sharing Statement

Citations:

PubMed Identifier

20477993

Citation

Foss A, Adam R, Dueland S. Liver transplantation for colorectal liver metastases: revisiting the concept. Transpl Int. 2010 Jul;23(7):679-85. doi: 10.1111/j.1432-2277.2010.01097.x. Epub 2010 Apr 30.

Results Reference

derived

Learn more about this trial

Liver Transplantation and Metastatic Colo-rectal Cancer.

We'll reach out to this number within 24 hrs